Fearing the disease or the vaccine: The case of COVID-19.

COVID-19 Coronavirus Perceived risk Perceived vaccine safety Vaccination intentions Vaccine hesitancy

Journal

Personality and individual differences
ISSN: 0191-8869
Titre abrégé: Pers Individ Dif
Pays: England
ID NLM: 8006972

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 07 10 2020
revised: 03 12 2020
accepted: 06 12 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: ppublish

Résumé

As studies indicate that people perceive COVID-19 as a threatening disease, the demand for a vaccine against the disease could be expected to be high. Vaccine safety concerns might nevertheless outweigh the perceived disease risks when an individual decides whether or not to accept the vaccine. We investigated the role of perceived risk of COVID-19 (i.e., perceived likelihood of infection, perceived disease severity, and disease-related worry) and perceived safety of a prospective vaccine against COVID-19 in predicting intentions to accept a COVID-19 vaccine. Three Finnish samples were surveyed: 825 parents of small children, 205 individuals living in an area with suboptimal vaccination coverage, and 1325 Facebook users nationwide. As points of reference, we compared the perceptions of COVID-19 to those of influenza and measles. COVID-19 was perceived as a threatening disease-more so than influenza and measles. The strongest predictor of COVID-19 vaccination intentions was trusting the safety of the potential vaccine. Those perceiving COVID-19 as a severe disease were also slightly more intent on taking a COVID-19 vaccine. Informing the public about the safety of a forthcoming COVID-19 vaccine should be the focus for health authorities aiming to achieve a high vaccine uptake.

Identifiants

pubmed: 33518869
doi: 10.1016/j.paid.2020.110590
pii: S0191-8869(20)30781-9
pmc: PMC7832025
doi:

Types de publication

Journal Article

Langues

eng

Pagination

110590

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

None.

Références

Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27285-27291
pubmed: 33060298
Vaccine. 2011 Sep 2;29(38):6472-84
pubmed: 21756960
Int J Ment Health Addict. 2021;19(5):1875-1888
pubmed: 32346359
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Emerg Infect Dis. 2020 Jul;26(7):1575-1579
pubmed: 32298227
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Nature. 2020 Apr;580(7805):576-577
pubmed: 32346146
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Health Psychol. 2007 Mar;26(2):136-45
pubmed: 17385964
Res Social Adm Pharm. 2021 Jan;17(1):1859-1866
pubmed: 33317765
PLoS One. 2019 Oct 31;14(10):e0224330
pubmed: 31671115
Psychol Med. 2020 Dec 11;:1-15
pubmed: 33305716
Soc Sci Med. 2019 Nov;240:112552
pubmed: 31561111
Psychol Bull. 2001 Mar;127(2):267-86
pubmed: 11316014
J Public Health (Oxf). 2018 Dec 1;40(4):e531-e537
pubmed: 29554290
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Int J Epidemiol. 2018 Feb 1;47(1):15-16j
pubmed: 29025073
Vaccine. 2019 Mar 7;37(11):1398-1406
pubmed: 30739794
R Soc Open Sci. 2020 Oct 14;7(10):201199
pubmed: 33204475
Prev Chronic Dis. 2020 Jul 16;17:E63
pubmed: 32678061
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
Disaster Med Public Health Prep. 2015 Apr;9(2):207-19
pubmed: 25882127
R Soc Open Sci. 2020 Sep 16;7(9):200742
pubmed: 33047037
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Lancet Infect Dis. 2021 Mar;21(3):318-319
pubmed: 32619436
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676
Curr Neurol Neurosci Rep. 2018 Jun 1;18(7):43
pubmed: 29855798
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Health Psychol. 2007 Mar;26(2):146-51
pubmed: 17385965
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
Risk Anal. 2004 Apr;24(2):311-22
pubmed: 15078302

Auteurs

Linda C Karlsson (LC)

Department of Psychology, Åbo Akademi University, Finland.

Anna Soveri (A)

FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University of Turku, Finland.

Stephan Lewandowsky (S)

School of Psychological Science, University of Bristol, United Kingdom.
School of Psychological Science, University of Western Australia, Australia.

Linnea Karlsson (L)

FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University of Turku, Finland.
Centre for Population Health Research, University of Turku and Turku University Hospital, Finland.
Department of Child Psychiatry, Turku University Hospital and University of Turku, Finland.

Hasse Karlsson (H)

FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University of Turku, Finland.
Centre for Population Health Research, University of Turku and Turku University Hospital, Finland.
Department of Psychiatry, Turku University Hospital and University of Turku, Finland.

Saara Nolvi (S)

FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University of Turku, Finland.
Turku Institute for Advanced Studies, Department of Psychology and Speech-Language Pathology, University of Turku, Finland.
Department of Medical Psychology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany.

Max Karukivi (M)

FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University of Turku, Finland.
Department of Psychiatry, Turku University Hospital and University of Turku, Finland.

Mikael Lindfelt (M)

Department of Theological Ethics, Åbo Akademi University, Finland.

Jan Antfolk (J)

Department of Psychology, Åbo Akademi University, Finland.

Classifications MeSH